Global Bone Growth Stimulator Market Report Analysed by Size, Share, Growth, Industry Demand and Forecast

According to the new market research report “Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) – Global Forecasts to 2026″, published by MarketsandMarkets™, the global bone growth stimulation devices market is projected to reach USD 1.5 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.8% during the forecast period.

Growth Driver: Growing patient preference for non-invasive and minimally invasive surgical treatments

The demand for minimally invasive procedures has witnessed a significant increase owing to the advantages offered by these procedures over traditional treatment procedures. The key advantages of minimally invasive procedures include fewer operative complications, shorter hospitalization, less pain, smaller and more cosmetic incisions, lower risk of infection, reduced postoperative care, and quicker recovery. Minimally invasive procedures make use of advanced technologies to diagnose and treat various diseases, including cancer. These procedures are used as an effective approach for removing cancer tumors and lymph nodes without scarring.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383

The Rise in the global incidence of AKI and increase in the demand for effective renal replacement therapy among ICU patients and initiatives undertaken by governments to increase the awareness about BGS therapy along with the increase in the launch of advanced BGS system area anticipated to fuel the bone growth stimulation devices market growth during the forecast period.

These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. The growing patient preference for non-invasive and minimally invasive surgical treatments, the rising prevalence of target conditions, and the growing number of sports and accident-related orthopedic injuries are the key factors driving the growth of the bone growth stimulators market. However, limited medical reimbursement for bone stimulation devices, high treatment costs associated with BMP and PRP products, and side effects associated with BMP-based orthopedic treatment are the key factors restraining the growth of bone growth stimulation devices market.

The growing demand for orthopedic injuries to support the market growth during the forecast period.

The significant rise in demand for BGS in the treatment of orthopedic patients. Moreover, the development and commercialization of BGS products also support Bone Growth Stimulator Market growth. Furthermore, many companies are expanding their BGS (PRP products) product portfolios. Similarly, the companies are also expanding their presence in the market. For instance, in 2021, Orthofix entered into an exclusive license agreement to commercialize the innovative portfolio of IGEA’s bone, cartilage, and soft tissue stimulation products in the US and Canada.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383

Asia Pacific likely to emerge as the fastest-growing BGS market.

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for Bone Growth Stimulator Market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 8.7% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with orthopedic disease, are factors likely to support the growth of market in the region.

The prominent players operating in the global Bone Growth Stimulator Market include Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India) among others.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=82341383

Bone Growth Stimulator Market Key Players, Share, Trend, Segmentation and Forecast

[153 Pages Report] The Global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.

Hospitals and Clinics Form the Fastest Growing End User Segment of the market.

Home care end users segment include patients who use external bone growth stimulator market; based on a physician’s prescription. Physicians recommend these stimulators to patients who have undergone spinal fusion surgery or are suffering from bone fractures that have failed to heal in the normal period of time (delayed or nonunion fracture). This segment is expected to witness growth due to rising physician preference for bone growth stimulators over their counterparts, cost-effectiveness of external stimulators in the case of nonunion fractures, government recommendations for the use of external stimulators, and the availability of reimbursement and insurance coverage.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383

key players in the Bone Growth Stimulator Market:

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the market.

Major Market Developments in Market:

# Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.

# Zimmer Holdings merged with Biomet, Inc., a U.S.-based company engaged in the development of musculoskeletal medical products. This merger helped both companies to expand their footprints in the global musculoskeletal devices market and strengthen its position in the Bone Growth Stimulators Market.

# Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383

Geographical Growth Analysis in Detailed:

The Bone Growth Stimulator Market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.

2019 Global Bone Growth Stimulators Market Report- Opportunities in Future with Different Segments

The Global Bone Growth Stimulators Market is expected to reach $ 1.41 billion, at a CAGR of 5.4%

The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this Bone Growth Stimulators Market.

Bone growth Stimulator Market by devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures. These devices have been reported to shorten the patient’s hospital stay as well as lessen the risks of complications and infections.

Download PDF (Bone Growth Stimulator):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383

Bone Growth Stimulators Market segmentation:

· based on products.

· based on application.

· based on end users.

· based on regions.

Hospitals and Clinics Form the Fastest Growing End-User Segment.

Hospitals:

This segment includes both government and private hospitals that provide treatment or conduct surgeries related to spine, oral and maxillofacial, nonunion/delayed union fractures and dental practices. An increasing patient population, rising procedural volumes of spinal fusion surgeries, growing prevalence of spinal disorders, and growing awareness on bone growth stimulation products are aiding the growth of this segment.

The Major Players Operating in the Bone Growth Stimulators Market:

Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.) are some of the key players in the bone growth stimulators market.

Geographical Detailed Analysis for Bone Growth Stimulators Market:

The bone growth stimulators market is classified into North America, Europe, Asia-Pacific, and the Rest of the World.

The global bone growth stimulator market was dominated by North America mainly due to the growing elderly population, increasing the incidence of arthritis and sports injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries. rising awareness among healthcare professionals related to the novel and upcoming treatment options, and ongoing government initiatives to modernize & expand healthcare infrastructure.

The Asia-pacific market is expected to grow at the highest CAGR during the Forecast Period.

Read More in Detailed (Bone Growth Stimulators):

https://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-82341383.html

Global Bone Growth Stimulator Market Size, Market Growth Projection to 2022

[153 Pages Report] The global Bone Growth Stimulator Market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.

The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.

Don’t miss out on business opportunities in Bone Growth Stimulator Market.

Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.

Market Dynamics

Drivers

• Growing patient preference for noninvasive and minimally invasive surgical treatments
• Increasing target patient population
• Procedural benefits offered by bone stimulation devices in bone fracture treatment

Restraints

• Limited medical reimbursement for bone stimulation products
• High treatment costs associated with BMP and PRP products

Opportunity

• Emerging markets

Speak to our analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383

The Major Objectives of the study:

• To define, describe, and forecast the global Bone Growth Stimulator Market on the basis of product, application, and end user
• To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To provide market size for various segments of the Bone Growth Stimulator Market with respect to four main geographies, namely, North America (U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and Rest of the World

Browse and in-depth TOC on “Bone Growth Stimulator Market”

66 — Tables

67 — Figures

153 — Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-82341383.html

Major Market Developments:

• In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.
• In 2016, Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.

Request for Free Sample Report @

https://www.marketsandmarkets.com/requestsample.asp?id=82341383

Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the Bone Growth Stimulator Market.

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

2018 Global Bone Growth Stimulator Market Report- Opportunities in Future with Different Segments

The report studies the Bone Growth Stimulator Market is expected to reach USD 1.41 Billion by 2022 growing at a CAGR of 5.4%.

According to a new market research report “Bone Growth Stimulators Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Home care, Academia, CROs) — Global Forecasts to 2022”, published by MarketsandMarkets™.

The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market.

Bone Growth Stimulator Market

Browse 66 market data Tables and 67 Figures spread through 153 Pages and in-depth TOC on “Bone Growth Stimulator Market”

http://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-82341383.html

On the basis of product, the global Bone Growth Stimulators Market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The bone growth stimulation devices segment accounted for the largest share of the market.

Bone Growth Stimulator Market, by Product

• Bone Growth Stimulation Devices
• External Bone Growth Stimulators
• Capacitive Coupling (CC) Devices
• Pulsed Electromagnetic Field (PEMF) Devices

On the basis of application, the global Bone Growth Stimulators Market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment accounted for the largest share of the market in 2016.

Download PDF Brochure:http://www.marketsandmarkets.com/pdfdownload.asp?id=82341383

The large share of this segment is attributed to the growing geriatric population, rising number of spine procedures (and rate of spinal fusion failure), established safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation products.

On the basis of end user, the global Bone Growth Stimulators Market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The advantage of bone growth stimulation products over their counterparts is the key factor driving their adoption in this end-user segment.

Bone Growth Stimulator Market, by End User;

• Hospitals and Clinics
• Home Care
• Academic & Research Institutes and CROs

On the basis of region, this Bone Growth Stimulators Market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global Bone Growth Stimulators Market was dominated by North America mainly due to the growing elderly population, increasing incidence of arthritis and sports injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries.

Talk To Our Research Analysts:http://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383

However, the Asia-Pacific market is expected to grow at the highest CAGR during 2017–2022. This is primarily due to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), rising awareness among healthcare professionals related to novel and upcoming treatment options, and ongoing government initiatives to modernize & expand healthcare infrastructure.

Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.) are some of the key players in the Bone Growth Stimulators Market.

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:
 Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Bone Growth Stimulator Market size 2018 Global Market Analyze by Growth Analysis, Trends and Regions 2022

The Bone Growth Stimulator Market is projected to reach USD 1.41 Billion by 2022 at a CAGR of 5.4%.

The Research Report on Bone Growth Stimulator Market, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2022, published by MarketsandMarkets™, the report studies the global Bone Growth Stimulator market over the forecast period to 2022.

The major factors driving the growth of the bone growth stimulators market are growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments. In this report, the market has been segmented by product, end user, application, and region.

Based on product, the market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The platelet-rich plasma (PRP) segment is projected to be the fastest growing segment during the forecast period. This growth can primarily be attributed to the increasing use of PRP in sports injuries and the expansion of its applications (due to a growing number of clinical trials).

By end user, the market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The advantage of bone growth stimulation products over their counterparts is the key factor driving their adoption in this end-user segment.

The study estimates the Bone Growth Stimulator market size for 2018 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, Bone Growth Stimulator specialists, laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies and academic research institutes.

For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the Bone Growth Stimulator market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The Bone Growth Stimulator market is fragmented with the presence of emerging players;

Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S)…..Read More

Request a Sample Copy of “Bone Growth Stimulator Market” Consist 66 tables and 67 figures spread over 153 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=82341383

Bone Growth Stimulator Market, by Product;

· Bone Growth Stimulation Devices

• Bone Morphogenetic Proteins (BMP)
• Platelet-rich Plasma (PRP)

Bone Growth Stimulator Market, by End User;

• Hospitals and Clinics
• Home Care

Bone Growth Stimulator Market, by Application;

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral and Maxillofacial Surgeries

Bone Growth Stimulator Market, by Region;

· North America (US, Canada)

· Europe (UK, Germany, Others)

· Asia

· Rest of the World

For any queries Speak to our Analyst:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383

Major Key Points from Table of Content:

· Introduction

· Research Methodology

· Bone Growth Stimulator Market, By End User

· Bone Growth Stimulator Market, By Application

· Competitive Landscape

· Company Profiles

The Objectives Covered in This Research Report:

• To define, describe, and forecast the global Bone Growth Stimulator market based on product, application, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities and industry-specific challenges)
• To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders.

Major Key Points from List of Tables (Consist of 66 Tables):

· Global Bone Growth Stimulators Market Size, By Product

· PEMF Devices Market Size, By Region

· CMF Devices Market Size, By Region

· Ultrasonic Bone Growth Stimulators Market Size, By Region

· Platelet-Rich Plasma Market Size, By Region

· Market Size for Spinal Fusion Surgeries, By Region

· Global Market Size for Academic & Research Institutes and CROS, By Region

· North America: External Bone Growth Stimulator Market Size, By Type

· Canada: Bone Growth Stimulator Market Size, By Product

· Europe: Bone Growth Stimulator Market Size, By Country……. Click To Read Full Toc

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownload.asp?id=82341383

Major Key Points from List of Figures (Consist of 67 Figures):

· Global Bone Growth Stimulators Market: Research Methodology Steps

· Geriatric Population, By Region, 2015 vs 2030 vs 2050 (Million)

· Bone Growth Stimulators Market Size, By Product

· Increasing Target Patient Population — Primary Growth Driver of the Market

· Spinal Fusion Surgeries Segment Will Continue to Dominate the Bone Growth Stimulator Market in 2022

· Hospitals & Clinics Segment to Account for the Largest Share of the Global Bone Growth Stimulator Market

· North America: Market Snapshot

· Orthofix International N.V.: Company Snapshot

· DJO Finance LLC: Business Strategy Scorecard

· Zimmer Biomet Holdings, Inc.: Product Offering Scorecard

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:

Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com